Roche’s Virtual Event following Angiogenesis 2021

Roche has hosted a virtual event on Tuesday, 16^th February 2021.

Agenda:

Welcome
Karl Mahler, Head of Investor Relations and Roche Group Planning
Ophthalmology Strategy Update
Atul Dandekar, Vice President and Global Franchise Head of Ophthalmology Product Strategy
Ophthalmology Pipeline Update
Christopher Brittain, Vice President and Global Head of Ophthalmology Product Development
Faricimab in DME and nAMD – Phase III results
Nancy Holekamp, M.D., Retina Specialist and Clinical Investigator
Q&A

Please register to access the webcast replay.*

First Name

Last name

Corporate Email

Company Name

Job Role

Country

* Mandatory

Please come back 30 minutes before the webcast start date and fill in the registration form.